Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A European Multicenter Open-Label Randomised Trial to Evaluate the Efficacy and Safety of Sirolimus and Tacrolimus Compared to MMF and Tacrolimus With Short-Course Induction Therapy, Short-Term Steroids Application in de Novo SPK Transplanted Diabetic Patients

NCT00140543 is registered in ClinicalTrials.gov with EUROSPK Study Group as lead sponsor.

NCT NCT00140543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A European Multicenter Open-Label Randomised Trial to Evaluate the Efficacy and Safety of Sirolimus and Tacrolimus Compared to MMF and Tacrolimus With Short-Course Induction Therapy, Short-Term Steroids Application in de Novo SPK Transplanted Diabetic Patients
Lead sponsor
EUROSPK Study Group
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2002
Completion date
September 30, 2005
Enrollment
228
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, diabetic nephropathy